Published in Lancet on February 17, 1990
Halofantrine pharmacokinetics in Kenyan children with non-severe and severe malaria. Br J Clin Pharmacol (1995) 0.93
Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet (1996) 3.40
Imported Falciparum malaria in Europe: sentinel surveillance data from the European network on surveillance of imported infectious diseases. Clin Infect Dis (2002) 2.44
HIV transmission by oral sex. Lancet (1988) 2.27
Virus excretion in the cervicovaginal secretions of pregnant and nonpregnant HIV-infected women. J Acquir Immune Defic Syndr (1993) 1.91
Nitric oxide in cerebral malaria. J Infect Dis (1994) 1.64
Albendazole as a potential treatment for human hydatidosis. Lancet (1983) 1.62
Amodiaquine remains effective for treating uncomplicated malaria in west and central Africa. Trans R Soc Trop Med Hyg (2000) 1.51
High levels of circulating IL-10 in human malaria. Clin Exp Immunol (1994) 1.41
[Plasmodium falciparum malaria: type R1 resistance to quinine in west Africa]. Presse Med (1998) 1.38
In vitro antimalarial activity of limonoids from Khaya grandifoliola C.D.C. (Meliaceae). J Ethnopharmacol (2000) 1.37
Age as a risk factor for severe manifestations and fatal outcome of falciparum malaria in European patients: observations from TropNetEurop and SIMPID Surveillance Data. Clin Infect Dis (2003) 1.29
Molecular basis of in vivo resistance to sulfadoxine-pyrimethamine in African adult patients infected with Plasmodium falciparum malaria parasites. Antimicrob Agents Chemother (1998) 1.28
Sequence variations in the genes encoding dihydropteroate synthase and dihydrofolate reductase and clinical response to sulfadoxine-pyrimethamine in patients with acute uncomplicated falciparum malaria. J Infect Dis (2000) 1.22
Risk factors for negative sputum acid-fast bacilli smears in pulmonary tuberculosis: results from Dakar, Senegal, a city with low HIV seroprevalence. Int J Tuberc Lung Dis (1999) 1.20
Analysis of the key pfcrt point mutation and in vitro and in vivo response to chloroquine in Yaoundé, Cameroon. J Infect Dis (2001) 1.20
In vitro activity of lumefantrine (benflumetol) against clinical isolates of Plasmodium falciparum in Yaoundé, Cameroon. Antimicrob Agents Chemother (1998) 1.20
[Plasmodium falciparum: interpretation of the semi-microtest of in vitro chemosensitivity by H3-hypoxanthine incorporation]. Pathol Biol (Paris) (1984) 1.20
Cutaneous larva migrans in travelers: a prospective study, with assessment of therapy with ivermectin. Clin Infect Dis (2000) 1.12
Resting energy expenditure is increased in stable, malnourished HIV-infected patients. Am J Clin Nutr (1991) 1.09
Kinetics of lymphocyte subsets from peripheral blood during a Plasmodium falciparum malaria attack. Clin Exp Immunol (1992) 1.09
HIV-1 and HIV-2 AIDS in African patients living in Paris. AIDS (1997) 1.07
Isotypic analysis of maternally transmitted Plasmodium falciparum-specific antibodies in Cameroon, and relationship with risk of P. falciparum infection. Clin Exp Immunol (1997) 1.06
False chloroquine resistance in Africa. Lancet (1997) 1.06
Molecular epidemiology of malaria in Yaoundé, Cameroon. III. Analysis of chloroquine resistance and point mutations in the multidrug resistance 1 (pfmdr 1) gene of Plasmodium falciparum. Am J Trop Med Hyg (1998) 1.05
Resting energy expenditure in human immunodeficiency virus-infected patients: comparison between patients with and without secondary infections. Am J Clin Nutr (1993) 1.05
Pulmonary complications of human immunodeficiency virus infection in Bujumbura, Burundi. Am Rev Respir Dis (1993) 1.04
Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil. Am J Trop Med Hyg (2000) 1.03
Immune response to Plasmodium falciparum liver stage antigen-1: geographical variations within Central Africa and their relationship with protection from clinical malaria. Trans R Soc Trop Med Hyg (2000) 1.02
Immune responses against Plasmodium falciparum asexual blood-stage antigens and disease susceptibility in Gabonese and Cameroonian children. Am J Trop Med Hyg (1999) 1.01
[Surveillance of falciparum malaria susceptibility to antimalarial drugs and policy change in the Comoros]. Bull Soc Pathol Exot (2007) 1.01
Immune response to Plasmodium falciparum antigens in Cameroonian primigravidae: evolution after delivery and during second pregnancy. Clin Exp Immunol (1997) 1.00
Primary prevention with cotrimoxazole for HIV-1-infected adults: results of the pilot study in Dakar, Senegal. J Acquir Immune Defic Syndr (2001) 1.00
Chloroquine-potentiating action of antihistaminics in Plasmodium falciparum in vitro. Ann Trop Med Parasitol (1991) 1.00
Vertical transmission of HIV-2. Lancet (1990) 1.00
Site-based study on polymorphism of Plasmodium falciparum MSP-1 and MSP-2 genes in isolates from two villages in Central Africa. Parassitologia (2000) 1.00
Malaria cellular immune responses in neonates from Cameroon. Parasite Immunol (1996) 0.99
Multiple opportunistic infection in a male homosexual in France. Lancet (1982) 0.97
Treatment of imported cases of falciparum malaria in France with halofantrine. Trans R Soc Trop Med Hyg (1986) 0.97
Failure of anti-malarial prophylaxis with mefloquine in Africa. Trans R Soc Trop Med Hyg (1991) 0.96
Nutritional status of HIV-seropositive subjects in an AIDS clinic in Paris. Eur J Clin Nutr (1997) 0.95
Plasmodium falciparum: drug sensitivity in vitro of isolates before and after adaptation to continuous culture. Exp Parasitol (1983) 0.95
Cerebellar syndrome in mild Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg (1988) 0.95
Visceral leishmaniasis and HIV infection: unusual presentation with pleuropulmonary involvement, and effect of secondary prophylaxis. AIDS (1992) 0.94
[Epidemic of trichinosis of Egyptian origin. Apropos of 6 cases observed in Paris]. Ann Med Interne (Paris) (1976) 0.94
Molecular epidemiology of malaria in Yaounde, Cameroon II. Baseline frequency of point mutations in the dihydropteroate synthase gene of Plasmodium falciparum. Am J Trop Med Hyg (1998) 0.93
Herpes simplex esophagitis in patients with AIDS: report of 34 cases. The Cooperative Study Group on Herpetic Esophagitis in HIV Infection. Clin Infect Dis (1996) 0.93
Molecular epidemiology of malaria in Yaounde, Cameroon IV. Evolution of pyrimethamine resistance between 1994 and 1998. Am J Trop Med Hyg (1999) 0.92
[Surveillance of the in vivo sensitivity of Plasmodium falciparum to antimalarial agents: the results of initial tests of the OCEAC Malaria Network]. Med Trop (Mars) (1997) 0.92
Molecular epidemiology of malaria in Yaounde, Cameroon. VII. Analysis of recrudescence and reinfection in patients with uncomplicated falciparum malaria. Am J Trop Med Hyg (2001) 0.91
Clinical efficacy and pharmacokinetics of micronized halofantrine for the treatment of acute uncomplicated falciparum malaria in nonimmune patients. Am J Trop Med Hyg (1994) 0.91
Plasma levels of TNF-alpha soluble receptors correlate with outcome in human falciparum malaria. Eur Cytokine Netw (1994) 0.91
Atovaquone plus proguanil versus halofantrine for the treatment of imported acute uncomplicated Plasmodium falciparum malaria in non-immune adults: a randomized comparative trial. Am J Trop Med Hyg (2001) 0.91
Heterogeneity in the circumsporozoite protein gene of Plasmodium malariae isolates from sub-Saharan Africa. Mol Biochem Parasitol (1998) 0.90
Efficacy of zidovudine in preventing relapses of Salmonella bacteremia in AIDS. J Infect Dis (1991) 0.90
Monitoring of the therapeutic efficacy of chloroquine for the treatment of uncomplicated, Plasmodium falciparum malaria in Iran. Ann Trop Med Parasitol (2006) 0.90
HIV-2/LAV-2 in Portuguese man with AIDS (Paris, 1978) who had served in Angola in 1968-74. Lancet (1987) 0.90
Onychomycosis and AIDS. Clinical and laboratory findings in 62 patients. Int J Dermatol (1990) 0.90
[Bacteremia and septicemia due to Serratia marcescens. Apropos of 50 positive hemocultures (26 patients)]. Ann Med Interne (Paris) (1969) 0.89
[Treatment of the cutaneous larva migrans syndrome "Larbish" with albendazole. Apropos of 18 cases]. Bull Soc Pathol Exot Filiales (1982) 0.89
Randomized comparison of amphotericin B deoxycholate dissolved in dextrose or Intralipid for the treatment of AIDS-associated cryptococcal meningitis. Clin Infect Dis (1996) 0.88
Diagnosis of Plasmodium malariae infection by the polymerase chain reaction. Trans R Soc Trop Med Hyg (1997) 0.88
[Digestive manifestations in acquired immunodeficiency disease]. Ann Med Interne (Paris) (1987) 0.88
[Plasmodium falciparum chemoresistance. The situation in Africa in 1989]. Med Trop (Mars) (1990) 0.88
Relationships between malaria prevalence and malaria-related morbidity in school children from two villages in central Africa. Am J Trop Med Hyg (1999) 0.88
Molecular epidemiology of malaria in Yaounde, Cameroon. VIII. Multiple Plasmodium falciparum infections in symptomatic patients. Am J Trop Med Hyg (2001) 0.88
In-vitro activity of primaquine against the asexual blood stages of Plasmodium falciparum. Ann Trop Med Parasitol (1999) 0.88
Type RI resistance to halofantrine in West Africa. Trop Med Parasitol (1991) 0.87
Abnormal free fatty acids and cortisol concentrations in the serum of AIDS patients. Eur J Cancer Clin Oncol (1988) 0.87
pfmdr1 gene mutation and clinical response to chloroquine in Yaoundé, Cameroon. Trans R Soc Trop Med Hyg (1997) 0.86
Prospective evaluation of a flow chart using a risk assessment for the diagnosis of STDs in primary healthcare centres in Libreville, Gabon. Sex Transm Infect (1998) 0.86
Cardiac effects of amodiaquine and sulfadoxine-pyrimethamine in malaria-infected African patients. Am J Trop Med Hyg (2001) 0.85
Molecular epidemiology of malaria in Yaounde, Cameroon I. Analysis of point mutations in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Am J Trop Med Hyg (1998) 0.85
[Hepatic necrosis secondary to tienilic acid therapy (author's transl)]. Therapie (1980) 0.85
Ivermectin in onchocerciasis. Lancet (1984) 0.85
[Geographic approach to the epidemiology of chloroquine-resistance of Plasmodium falciparum in tropical Africa]. Ann Soc Belg Med Trop (1991) 0.85
Assessment of three in vitro tests and an in vivo test for chloroquine resistance in Plasmodium falciparum clinical isolates. J Clin Microbiol (1998) 0.84
Evolution of chloroquine resistance in central and west Africa. Trop Med Parasitol (1993) 0.84
Albendazole: a new single dose anthelmintic. Study in 1455 patients. Acta Trop (1984) 0.83
[Drug-resistant malaria: problems with its definition and technical approaches]. Sante (2000) 0.83
[Immune complexes and complement in leprosy (author's transl)]. Nouv Presse Med (1981) 0.83
Assessment of pyronaridine activity in vivo and in vitro against the hepatic stages of malaria in laboratory mice. Trans R Soc Trop Med Hyg (2000) 0.82
AIDS in a Haitian couple in Paris. Lancet (1983) 0.82
[Stability of P. Falciparum resistance to chloroquine between 1987 and 1989 in Mounana, Gabon]. Bull World Health Organ (1992) 0.82
[Purulent meningitis from surgical inoculation of an anterior sacral meningocele: a rare complication of Marfan's disease (author's transl)]. Ann Med Interne (Paris) (1980) 0.82
Albendazole versus thiabendazole as therapy for trichinosis: a retrospective study. Clin Infect Dis (1996) 0.82
Antibodies to the PF155 antigen of Plasmodium falciparum: measurement by cell-ELISA and correlation with expected immune protection. Am J Trop Med Hyg (1987) 0.82
[Development and evaluation of screening algorithms for sexually transmitted diseases in pregnant women at Libreville, Gabon]. Sante (1996) 0.81
Circulating immune complexes in six patients with trichinosis. Clin Exp Immunol (1977) 0.81
Chloroquine-resistant falciparum malaria in the Congo. Lancet (1985) 0.80
[Treatment of human onchocerciasis with ivermectin]. Bull Soc Pathol Exot Filiales (1983) 0.80
Resistant malaria in children. Indian Pediatr (2001) 0.80
Susceptibility of African isolates of Plasmodium falciparum to artemisinin (qinghaosu). Trop Med Parasitol (1992) 0.80
[The influence of rifampicin upon the metabolism of isoniazid (author's transl)]. Nouv Presse Med (1978) 0.80
Evaluation of a new sulfadoxine sensitivity assay in vitro for field isolates of Plasmodium falciparum. Trans R Soc Trop Med Hyg (2001) 0.79
[Behçet's disease disclosed by recurrent meningitis and esophageal ulcers]. Ann Med Interne (Paris) (1995) 0.79
Chronotherapy of malaria: improved efficacy of timed chloroquine treatment of patients with Plasmodium falciparum infections. Trans R Soc Trop Med Hyg (1992) 0.79
[Malaria prophylaxis]. Rev Prat (1998) 0.79